Felger, Jennifer C.

Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications

Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience

Tryptophan and brain disordersStress Responses and Cortisol

Cited by 1,180

CYTOKINE TARGETS IN THE BRAIN: IMPACT ON NEUROTRANSMITTERS AND NEUROCIRCUITS: Review: Cytokine Targets in the Brain

Miller, A. H., Haroon, E., Raison, C. L., & Felger, J. C. (2013) · Depression and Anxiety

Tryptophan and brain disordersNeuroinflammation and Neurodegeneration Mechanisms

Cited by 892

Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression

Felger, J. C., Li, Z., Haroon, E., Woolwine, B. J., Jung, M. Y., Hu, X., & Miller, A. H. (2016) · Molecular Psychiatry

Tryptophan and brain disordersFunctional Brain Connectivity Studies

Cited by 620

What does plasma CRP tell us about peripheral and central inflammation in depression?

Felger, J. C., Haroon, E., Patel, T. A., Goldsmith, D. R., Wommack, E. C., Woolwine, B. J., Le, N.-A., Feinberg, R., Tansey, M. G., & Miller, A. H. (2020) · Molecular Psychiatry

Tryptophan and brain disordersTreatment of Major Depression

Cited by 448

Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder

Haroon, E., Daguanno, A. W., Woolwine, B. J., Goldsmith, D. R., Baer, W. M., Wommack, E. C., Felger, J. C., & Miller, A. H. (2018) · Psychoneuroendocrinology

Tryptophan and brain disordersTreatment of Major Depression

Cited by 291

Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression

Haroon, E., Fleischer, C. C., Felger, J. C., Chen, X., Woolwine, B. J., Patel, T., Hu, X. P., & Miller, A. H. (2016) · Molecular Psychiatry

Tryptophan and brain disordersTreatment of Major Depression

Cited by 250

Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression

Felger, J. C., Alagbe, O., Hu, F., Mook, D., Freeman, A. A., Sanchez, M. M., Kalin, N. H., Ratti, E., Nemeroff, C. B., & Miller, A. H. (2007) · Biological Psychiatry

Tryptophan and brain disordersStress Responses and Cortisol

Cited by 214

Chronic Interferon-α Decreases Dopamine 2 Receptor Binding and Striatal Dopamine Release in Association with Anhedonia-Like Behavior in Nonhuman Primates

Felger, J. C., Mun, J., Kimmel, H. L., Nye, J. A., Drake, D. F., Hernandez, C. R., Freeman, A. A., Rye, D. B., Goodman, M. M., Howell, L. L., et al. (2013) · Neuropsychopharmacology

Tryptophan and brain disordersNeurotransmitter Receptor Influence on Behavior

Cited by 214

Tyrosine metabolism during interferon-alpha administration: Association with fatigue and CSF dopamine concentrations

Felger, J. C., Li, L., Marvar, P. J., Woolwine, B. J., Harrison, D. G., Raison, C. L., & Miller, A. H. (2013) · Brain, Behavior, and Immunity

Tryptophan and brain disordersAmino Acid Enzymes and Metabolism

Cited by 176

Therapeutic Implications of Brain–Immune Interactions: Treatment in Translation

Miller, A. H., Haroon, E., & Felger, J. C. (2017) · Neuropsychopharmacology

Tryptophan and brain disordersNeuroinflammation and Neurodegeneration Mechanisms

Cited by 152

Brain dendritic cells in ischemic stroke: Time course, activation state, and origin

Felger, J. C., Abe, T., Kaunzner, U. W., Gottfried-Blackmore, A., Gal-Toth, J., McEwen, B. S., Iadecola, C., & Bulloch, K. (2010) · Brain, Behavior, and Immunity

Neuroinflammation and Neurodegeneration MechanismsAcute Ischemic Stroke Management

Cited by 148

The role of dopamine in inflammation-associated depression: mechanisms and therapeutic implications

Felger, J. C. (2016) · Current Topics in Behavioral Neurosciences

Tryptophan and brain disordersNeurotransmitter Receptor Influence on Behavior

Cited by 115

Influences of dopaminergic system dysfunction on late-life depression

Taylor, W. D., Zald, D. H., Felger, J. C., Christman, S., Claassen, D. O., Horga, G., Miller, J. M., Gifford, K., Rogers, B., Szymkowicz, S. M., et al. (2022) · Molecular Psychiatry

Neurotransmitter Receptor Influence on BehaviorTreatment of Major Depression

Cited by 89

Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression

Mehta, D., Raison, C. L., Woolwine, B. J., Haroon, E., Binder, E. B., Miller, A. H., & Felger, J. C. (2013) · Brain, Behavior, and Immunity

Tryptophan and brain disordersTreatment of Major Depression

Cited by 74

Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Randomized Dose-Finding Clinical Trial

Mischoulon, D., Dunlop, B. W., Kinkead, B., Schettler, P. J., Lamon-Fava, S., Rakofsky, J. J., Nierenberg, A. A., Clain, A. J., Crowe, T. M., Wong, A., et al. (2022) · The Journal of Clinical Psychiatry

Fatty Acid Research and HealthTryptophan and brain disorders

Cited by 56

Early activation of p38 mitogen activated protein kinase is associated with interferon-alpha-induced depression and fatigue

Felger, J. C., Alagbe, O., Pace, T. W. W., Woolwine, B. J., Hu, F., Raison, C. L., & Miller, A. H. (2011) · Brain, Behavior, and Immunity

Tryptophan and brain disordersStress Responses and Cortisol

Cited by 41

Neurotherapeutic Implications of Brain-Immune Interactions

Felger, J. C., & Miller, A. H. (2014) · Neuropsychopharmacology

Neuroinflammation and Neurodegeneration MechanismsTryptophan and brain disorders

Cited by 11

Correction to: Functional connectivity in reward circuitry and symptoms of anhedonia as therapeutic targets in depression with high inflammation: evidence from a dopamine challenge study

Bekhbat, M., Li, Z., Mehta, N. D., Treadway, M. T., Lucido, M. J., Woolwine, B. J., Haroon, E., Miller, A. H., & Felger, J. C. (2022) · Molecular Psychiatry

Treatment of Major DepressionFunctional Brain Connectivity Studies

Cited by 8